GERM Holdings
ETFMG Treatments, Testing and Advancements ETF
1W: +0.6%
1M: +3.0%
3M: -4.7%
1Y: -0.1%
3Y: -55.6%
$19.16
Last traded 2024-09-05 — delisted
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$10M
Holdings57
Top 10 Wt54.5%
Beta1.02
% Profitable33%
Coverage99%
Portfolio Valuation
P/E16.8
P/B0.6
P/S0.9
EV/EBITDA12.5
P/FCF5.9
PEG2.47
Profitability & Returns
Gross Margin66.1%
Net Margin4.6%
ROE3.2%
ROA1.6%
ROIC3.6%
Div Yield0.79%
Leverage & Liquidity
Debt/Equity0.66
Debt/Assets0.31
Net Debt/EBITDA3.2x
Interest Cov2.1x
Current Ratio1.19
Quick Ratio0.70
Growth (YoY)
Revenue+33.9%
Net Income+6.1%
EPS+9.3%
FCF+44.1%
EBITDA+14.3%
Rev CAGR 3Y+41.3%
Quality Scores
Piotroski F4.8
Altman Z2.50
IS Quality55.5
IS Overall45.7
IS Value41.9
Median P/E-1.7
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 53 | 99.3% | 2.0 |
| Financial Services | 1 | 0.3% | — |
| Other | 3 | 0.3% | — |
Smart Money Overlap
3 holdings with signals
Showing 50 of 57 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam Pharmaceuticals Inc | ALNY | 11.39% | $1.1M | 3,957 | 36.0 | $29.4B | Healthcare |
| 2 | Labcorp Holdings Inc | LH | 7.20% | $674,398 | 2,978 | 25.3 | $25.3B | Healthcare |
| 3 | Quest Diagnostics Inc | DGX | 6.61% | $618,442 | 4,142 | 24.4 | $25.7B | Healthcare |
| 4 | BioNTech SE | BNTX | 5.01% | $468,882 | 5,803 | -12.7 | $24.3B | Healthcare |
| 5 | Bio-Rad Laboratories Inc | BIO | 4.74% | $443,370 | 1,363 | 44.3 | $9.9B | Healthcare |
| 6 | Vaxcyte Inc | PCVX | 4.52% | $423,098 | 5,432 | -7.4 | $8.2B | Healthcare |
| 7 | QuidelOrtho Corp | QDEL | 4.11% | $384,985 | 9,250 | -0.7 | $734M | Healthcare |
| 8 | BioCryst Pharmaceuticals Inc | BCRX | 3.70% | $346,600 | 45,426 | -5.7 | $2.1B | Healthcare |
| 9 | Immunocore Holdings PLC | IMCR | 3.67% | $343,207 | 9,226 | -164.8 | $1.5B | Healthcare |
| 10 | Zai Lab Ltd | ZLAB | 3.60% | $337,054 | 20,729 | -14.4 | $2.7B | Healthcare |
| 11 | Moderna Inc | MRNA | 3.46% | $324,348 | 3,819 | -23.8 | $75.4B | Healthcare |
| 12 | Dynavax Technologies Corp | DVAX | 3.42% | $319,802 | 28,811 | 39.7 | $1.8B | Healthcare |
| 13 | ImmunityBio Inc | IBRX | 3.14% | $293,606 | 64,671 | -10.6 | $10.8B | Healthcare |
| 14 | Vir Biotechnology Inc | VIR | 2.79% | $260,847 | 29,948 | -6.0 | $1.9B | Healthcare |
| 15 | Novavax Inc | NVAX | 2.50% | $233,636 | 20,141 | -6.9 | $1.7B | Healthcare |
| 16 | OPKO Health Inc | OPK | 2.46% | $230,124 | 153,416 | -16.4 | $1.2B | Healthcare |
| 17 | CureVac NV | CVAC | 1.73% | $161,940 | 49,372 | 4.4 | $1.0B | Healthcare |
| 18 | Fulgent Genetics Inc | FLGT | 1.68% | $157,561 | 6,587 | -7.6 | $610M | Healthcare |
| 19 | Arbutus Biopharma Corp | ABUS | 1.62% | $151,617 | 41,539 | 5.6 | $879M | Healthcare |
| 20 | Adaptive Biotechnologies Corp | ADPT | 1.55% | $144,998 | 32,438 | -69.6 | $4.5B | Healthcare |
| 21 | SIGA Technologies Inc | SIGA | 1.45% | $136,042 | 15,655 | -77.5 | $242M | Healthcare |
| 22 | Arcturus Therapeutics Holdings Inc | ARCT | 1.14% | $107,178 | 5,928 | -3.9 | $370M | Healthcare |
| 23 | Gilead Sciences Inc | GILD | 1.01% | $94,653 | 1,285 | -55.7 | $179.5B | Healthcare |
| 24 | Regeneron Pharmaceuticals Inc | REGN | 0.99% | $92,762 | 82 | 17.6 | $75.7B | Healthcare |
| 25 | AbbVie Inc | ABBV | 0.98% | $91,926 | 484 | 74.0 | $464.3B | Healthcare |
| 26 | Johnson & Johnson | JNJ | 0.96% | $89,465 | 557 | 29.6 | $617.0B | Healthcare |
| 27 | Eli Lilly & Co | LLY | 0.93% | $87,385 | 98 | 38.2 | $1.1T | Healthcare |
| 28 | Sanofi SA | SNY | 0.92% | $86,253 | 1,647 | 21.7 | $95.9B | Healthcare |
| 29 | Abbott Laboratories | ABT | 0.91% | $85,011 | 782 | 31.4 | $168.7B | Healthcare |
| 30 | Takeda Pharmaceutical Co Ltd | TAK | 0.89% | $83,567 | 6,025 | 49.4 | $56.8B | Healthcare |
| 31 | AstraZeneca PLC | AZN | 0.88% | $81,921 | 1,009 | 23.4 | $243.3B | Healthcare |
| 32 | Emergent BioSolutions Inc | EBS | 0.87% | $81,776 | 11,534 | -1.8 | $327M | Healthcare |
| 33 | Pfizer Inc | PFE | 0.86% | $80,825 | 2,831 | 36.7 | $158.4B | Healthcare |
| 34 | GSK PLC | GSK | 0.84% | $79,030 | 1,963 | 14.8 | $94.2B | Healthcare |
| 35 | Merck & Co Inc | MRK | 0.76% | $71,594 | 625 | 114.5 | $356.4B | Healthcare |
| 36 | Ocugen Inc | OCGN | 0.76% | $70,809 | 56,647 | -4.0 | $346M | Healthcare |
| 37 | OraSure Technologies Inc | OSUR | 0.73% | $68,258 | 16,175 | -5.7 | $273M | Healthcare |
| 38 | Atea Pharmaceuticals Inc | AVIR | 0.66% | $62,072 | 18,419 | -2.5 | $411M | Healthcare |
| 39 | Enanta Pharmaceuticals Inc | ENTA | 0.62% | $58,271 | 4,632 | -5.4 | $377M | Healthcare |
| 40 | Inovio Pharmaceuticals Inc | INO | 0.52% | $48,494 | 5,746 | -1.0 | $80M | Healthcare |
| 41 | CorMedix Inc | CRMD | 0.49% | $45,932 | 12,024 | 3.0 | $564M | Healthcare |
| 42 | XBiotech Inc | XBIT | 0.48% | $44,509 | 6,754 | -1.5 | $67M | Healthcare |
| 43 | Cash & Other Cash | Cash&Other | 0.35% | $33,199 | 33,199 | — | — | — |
| 44 | Invesco Government & Agency Portfolio 12/31/2031 | AGPXX | 0.35% | $32,913 | 32,913 | — | $79.1B | Financial Services |
| 45 | Invivyd Inc | IVVD | 0.29% | $27,251 | 26,457 | -2.1 | $242M | Healthcare |
| 46 | Vaxart Inc | VXRT | 0.24% | $22,743 | 39,212 | 2.9 | $106M | Healthcare |
| 47 | Renovaro Inc | RENB | 0.22% | $20,279 | 32,708 | -1.7 | $33M | Healthcare |
| 48 | InflaRx NV | IFRX | 0.19% | $18,019 | 13,057 | -3.1 | $253M | Healthcare |
| 49 | HilleVax Inc | HLVX | 0.19% | $17,510 | 10,944 | -0.7 | $105M | Healthcare |
| 50 | Chimerix Inc | CMRX | 0.18% | $16,436 | 19,874 | -8.6 | $801M | Healthcare |